MARKET

MDGL

MDGL

Madrigal Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

85.38
-0.34
-0.40%
After Hours: 85.38 0 0.00% 16:00 01/17 EST
OPEN
86.28
PREV CLOSE
85.72
HIGH
86.44
LOW
84.64
VOLUME
224.22K
TURNOVER
--
52 WEEK HIGH
148.18
52 WEEK LOW
82.31
MARKET CAP
1.32B
P/E (TTM)
-19.4015
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MDGL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MDGL News

  • 10 Biggest Price Target Changes For Thursday
  • Benzinga.01/09 15:43
  • Benzinga's Top Upgrades, Downgrades For January 9, 2020
  • Benzinga.01/09 15:34
  • UBS Upgrades Madrigal Pharmaceuticals to Buy, Raises Price Target to $127
  • Benzinga.01/09 14:16
  • Madrigal Pharmaceuticals, Inc. (MDGL): Hedge Fund Sentiment Unchanged
  • Insider Monkey.12/20/2019 00:28

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About MDGL

Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and FH. MGL-3196 has completed Phase I single and multiple dose trials in healthy volunteers. MGL-3196 is being developed for dyslipidemia/hypercholesterolemia to lower low-density lipoproteins cholesterol, triglyceride levels and lipoprotein(a). MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
More

Webull offers Madrigal Pharmaceuticals Inc (MDGL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.